Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags.


Journal

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
ISSN: 1477-092X
Titre abrégé: J Oncol Pharm Pract
Pays: England
ID NLM: 9511372

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 30 11 2023
pubmed: 1 2 2023
entrez: 31 1 2023
Statut: ppublish

Résumé

Chemotherapy doses are usually prescribed on the basis of body surface area but dose banding is emerging as an efficient alternative. Dose banding presents the possibility of in-advance preparation in a Centralized Intravenous Admixture Service. To evaluate the long-term stability of 5-fluorouracil at banded doses (700 mg and 800 mg) in polyolefin bags. Ten polyolefin bags were prepared under aseptic conditions and stored at 23 ± 2°C for 24 days. Five of them were composed of 14 mL 5-fluorocuracil (700 g) in 100 mL 0.9% sodium chloride solution and the five other of 16 mL 5-fluorouracil (800 mg) in 100 mL 0.9% sodium chloride solution. At defined times, physical stability parameters were assessed: optical densities, pH measurements, visual and microscopical inspections. Solutions concentrations were measured using high-performance liquid chromatography coupled with a photodiode array detector. No change was observed on pH and optical density measurements during the study period. Visual and microscopical inspections remained free of colour change, precipitate, microagregate or crystal. The concentrations of 5-Fluorouracil in 800 mg bags remained stable for 24 days while the concentration in 700 mg bags showed a stability of at least 17 days. Five-fluorouracil at banded doses of 700 and 800 mg in polyolefin bags is physicochemically stable for at least 17 days at 23 ± 2°C. These results support the possibility of in advance centralised preparation.

Sections du résumé

BACKGROUND BACKGROUND
Chemotherapy doses are usually prescribed on the basis of body surface area but dose banding is emerging as an efficient alternative. Dose banding presents the possibility of in-advance preparation in a Centralized Intravenous Admixture Service.
AIM OF THE STUDY OBJECTIVE
To evaluate the long-term stability of 5-fluorouracil at banded doses (700 mg and 800 mg) in polyolefin bags.
MATERIALS AND METHODS METHODS
Ten polyolefin bags were prepared under aseptic conditions and stored at 23 ± 2°C for 24 days. Five of them were composed of 14 mL 5-fluorocuracil (700 g) in 100 mL 0.9% sodium chloride solution and the five other of 16 mL 5-fluorouracil (800 mg) in 100 mL 0.9% sodium chloride solution. At defined times, physical stability parameters were assessed: optical densities, pH measurements, visual and microscopical inspections. Solutions concentrations were measured using high-performance liquid chromatography coupled with a photodiode array detector.
RESULTS RESULTS
No change was observed on pH and optical density measurements during the study period. Visual and microscopical inspections remained free of colour change, precipitate, microagregate or crystal. The concentrations of 5-Fluorouracil in 800 mg bags remained stable for 24 days while the concentration in 700 mg bags showed a stability of at least 17 days.
CONCLUSION CONCLUSIONS
Five-fluorouracil at banded doses of 700 and 800 mg in polyolefin bags is physicochemically stable for at least 17 days at 23 ± 2°C. These results support the possibility of in advance centralised preparation.

Identifiants

pubmed: 36718964
doi: 10.1177/10781552231152618
doi:

Substances chimiques

PL 732 83136-87-2
Fluorouracil U3P01618RT
Sodium Chloride 451W47IQ8X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1878-1883

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Mélanie Closset (M)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Sabrina Onorati (S)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.

Marie-Lise Colsoul (ML)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Nicolas Goderniaux (N)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Benoît Bihin (B)

Scientific Support Unit, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Jacques Jamart (J)

Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Laura Soumoy (L)

Department of Pharmacy, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Jean-Daniel Hecq (JD)

Department of Pharmacy, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Pascal Odou (P)

Université de Lille, CHU Lille, ULR7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.

Laurence Galanti (L)

Medical Laboratory, CHU UCL Namur, Yvoir, Belgium.
Drug Stability Research Group, CHU UCL Namur, Yvoir, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH